Brief

Purdue Seeks Another Extension Of Mediation On New Plan

By Rick Archer · October 23, 2024, 7:26 PM EDT

OxyContin maker Purdue Pharma is asking a New York bankruptcy judge for another month to try to work out a replacement for its Chapter 11 plan and opioid settlement that were...

To view the full article, register now.

Bankruptcy Scorecard

Summary

Purdue Pharma filed for bankruptcy after reaching a settlement deal to end over 2,600 lawsuits that accused the maker of OxyContin of fueling a national opioid addiction crisis. In June 2024, the U.S. Supreme Court overturned Purdue's Chapter 11 plan finding non-debtor third parties, like Purdue's former owners the Sackler family, aren't authorized to receive non-consensual liability waivers under the U.S. Bankruptcy Code.

Case Number

19-bk-23649

Judge

Sean H. Lane

Venue

U.S. Bankruptcy Court for the Southern District of New York

Capital Structure

View Full Scorecard

Documents

Case Information

Case Title

Purdue Pharma L.P.

Case Number

7:19-bk-23649

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019